SA
CL icon

Strategic Advocates’s Colgate-Palmolive CL Stock Holding History

Strategic Advocates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05K Sell
24
-1,775
-99% -$158K 0.01% 210
2025
Q4 		$143K Buy
1,799
+347
+24% +$27.2K 0.04% 136
2025
Q3 		$116K Buy
+1,452
New +$124K 0.03% 158

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Strategic Advocates's CL Position: Q1 2026 in Review

Strategic Advocates reduced its Colgate-Palmolive (CL) stake by 99% in Q1 2026, selling an estimated $158K and leaving 24 shares worth $2.05K. The position accounts for 0.01% of the portfolio, ranked #210.

Strategic Advocates first reported a position in CL in Q3 2025 and has held it in 3 quarters since. The position peaked at $143K in Q4 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Strategic Advocates held 24 shares of Colgate-Palmolive worth $2.05K as of Q1 2026.
  • Strategic Advocates sold 1,775 Colgate-Palmolive shares in Q1 2026, an estimated $158K.
  • Colgate-Palmolive made up 0.01% of Strategic Advocates's portfolio in Q1 2026, its #210 holding.
  • Strategic Advocates first reported a position in Colgate-Palmolive in Q3 2025 and has held it in 3 quarters since.
  • Strategic Advocates's Colgate-Palmolive position peaked at $143K in Q4 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.